
Zura Bio
Biotechnology • Henderson, NV
About Zura Bio
Zura Bio is a clinical-stage biotechnology company developing immunology and inflammation therapies for autoimmune and inflammatory diseases. Its pipeline includes tibulizumab (a BAFF/IL-17 bispecific antibody) for systemic sclerosis and hidradenitis suppurativa, torudokimab (an anti-IL-33 antibody), and crebankitug (an anti-IL-7R antibody). The company aims to bring new treatment options to patients with immune-mediated diseases.


